Wolverine Trading, LLC Editas Medicine, Inc. Put Options Transaction History

Wolverine Trading, LLC

$93.9 Billion
Q3 2024

Put Options

21 transactions

Quarter	Operation	Price Per put	puts change	puts Held
Q3 2024 Nov 14, 2024	BUY	$3.39 - $5.96 $5,424 - $9,536	1,600 Added 14.95%	12,300 $41,000
Q2 2024 Aug 14, 2024	SELL	$4.67 - $7.28 $3,736 - $5,824	-800 Reduced 6.96%	10,700 $49,000
Q1 2024 May 15, 2024	BUY	$7.03 - $11.07 $80,845 - $127,305	11,500 New	11,500 $85,000
Q2 2023 Aug 23, 2023	BUY	$6.36 - $11.47 $75,048 - $135,346	11,800 New	11,800 $97,000
Q3 2022 Nov 14, 2022	BUY	$12.16 - $19.42 $66,880 - $106,810	5,500 Added 23.61%	28,800 $350,000
Q2 2022 Aug 15, 2022	SELL	$9.99 - $21.35 $206,793 - $441,945	-20,700 Reduced 47.05%	23,300 $285,000
Q1 2022 May 16, 2022	BUY	$14.08 - $27.63 $8,448 - $16,578	600 Added 1.38%	44,000 $859,000
Q4 2021 Feb 14, 2022	SELL	$26.55 - $40.57 $692,955 - $1.06 Million	-26,100 Reduced 37.55%	43,400 $1.21 Million
Q3 2021 Nov 12, 2021	BUY	$39.27 - $72.94 $475,167 - $882,574	12,100 Added 21.08%	69,500 $2.95 Million
Q2 2021 Aug 06, 2021	BUY	$31.29 - $56.64 $197,127 - $356,832	6,300 Added 12.33%	57,400 $2.65 Million
Q1 2021 May 14, 2021	SELL	$39.71 - $90.58 $194,579 - $443,842	-4,900 Reduced 8.75%	51,100 $2.07 Million
Q4 2020 Feb 12, 2021	BUY	$27.07 - $84.35 $1.52 Million - $4.72 Million	56,000 New	56,000 $4.28 Million
Q3 2020 Nov 13, 2020	SELL	$28.06 - $37.16 $544,364 - $720,903	-19,400 Closed	0 $0
Q2 2020 Aug 13, 2020	SELL	$18.5 - $34.34 $197,950 - $367,438	-10,700 Reduced 35.55%	19,400 $569,000
Q1 2020 May 11, 2020	SELL	$14.88 - $32.78 $1,488 - $3,278	-100 Reduced 0.33%	30,100 $610,000
Q4 2019 Feb 12, 2020	BUY	$19.49 - $32.63 $163,716 - $274,092	8,400 Added 38.53%	30,200 $891,000
Q3 2019 Nov 14, 2019	BUY	$22.49 - $26.81 $80,964 - $96,516	3,600 Added 19.78%	21,800 $490,000
Q2 2019 Aug 20, 2019	SELL	$20.48 - $27.76 $239,616 - $324,792	-11,700 Reduced 39.13%	18,200 $450,000
Q1 2019 May 15, 2019	SELL	$19.43 - $26.41 $613,988 - $834,556	-31,600 Reduced 51.38%	29,900 $731,000
Q4 2018 Feb 14, 2019	BUY	$18.19 - $31.79 $920,414 - $1.61 Million	50,600 Added 464.22%	61,500 $1.27 Million
Q3 2018 Nov 14, 2018	BUY	$27.65 - $38.39 $301,385 - $418,451	10,900 New	10,900 $347,000

Others Institutions Holding EDIT

# of Institutions

248

Shares Held

57M

Call Options Held

410K

Put Options Held

394K

Black Rock Inc. New York, NY

7.78M
Shares

$9.81 Million
0.0% of portfolio
Vanguard Group Inc Valley Forge, PA

6.68M
Shares

$8.42 Million
0.0% of portfolio
Deep Track Capital, LP Greenwich, CT

4.9M
Shares

$6.17 Million
0.62% of portfolio
Israel Englander Millennium Management LLC | New York, Ny

3.35M
Shares

$4.22 Million
0.01% of portfolio
State Street Corp Boston, MA

2.46M
Shares

$3.1 Million
0.0% of portfolio

View Full List

About Editas Medicine, Inc.

Ticker EDIT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 68,737,200
Market Cap $86.6M
Description
Editas Medicine, Inc., a clinical stage genome editing company, focuses on developing transformative genomic medicines to treat a range of serious diseases. It develops a proprietary gene editing platform based on CRISPR technology. The company develops EDIT-101, which is in Phase 1/2 clinical trial for Leber Congenital Amaurosis 10 that leads t...

More about EDIT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wolverine Trading, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Wolverine Trading, LLC with notifications on news.

Account